PMID- 15193448 OWN - NLM STAT- MEDLINE DCOM- 20040727 LR - 20091119 IS - 0165-4608 (Print) IS - 0165-4608 (Linking) VI - 152 IP - 1 DP - 2004 Jul 1 TI - A t(1;9)(q23.3 approximately q25;q34) affecting the ABL1 gene in a biphenotypic leukemia. PG - 81-3 AB - Recurring chromosome translocations, which are found in leukemia, can result in the inappropriate expression of oncogenes or in the formation of chimeric genes that code for structurally and functionally abnormal proteins. The chromosomal t(1;9)(q23.3 approximately q25;q34) was found in a patient with biphenotypic leukemia. Fluorescence in situ hybridization (FISH) analysis revealed that the break on chromosome 9 occurred in the ABL1 gene. The breakpoint on chromosome 1 occurred distal to the PBX1 gene at 1q23.3, as shown by FISH using BAC RP11-503N16 and RP11-403P14, which flank the PBX1 locus; hence, the ABL1 gene can be fused with another gene distal to PBX1 gene. FAU - Gonzalez Garcia, Juan Ramon AU - Gonzalez Garcia JR AD - Laboratorio de Citogenetica, Centro de Investigacion Biomedica de Occidente, Centro Medico Nacional de Occidente, Instituto Mexicano del Seguro Social (CIBO-IMSS), Colonia Independencia, Guadalajara, Jalisco, Mexico. jrgg_gene@hotmail.com FAU - Bohlander, Stefan K AU - Bohlander SK FAU - Gutierrez Angulo, Melva AU - Gutierrez Angulo M FAU - Esparza Flores, Maria Amparo AU - Esparza Flores MA FAU - Picos Cardenas, Veronica Judith AU - Picos Cardenas VJ FAU - Meza Espinoza, Juan Pablo AU - Meza Espinoza JP FAU - Ayala Madrigal, Maria de la Luz AU - Ayala Madrigal Mde L FAU - Rivera, Horacio AU - Rivera H LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cancer Genet Cytogenet JT - Cancer genetics and cytogenetics JID - 7909240 RN - EC 2.7.10.2 (Proto-Oncogene Proteins c-abl) SB - IM MH - Adolescent MH - Antineoplastic Combined Chemotherapy Protocols/therapeutic use MH - Chromosome Breakage MH - Chromosomes, Human, Pair 1/*genetics MH - Chromosomes, Human, Pair 9/*genetics MH - Gene Rearrangement MH - Humans MH - In Situ Hybridization, Fluorescence MH - Leukemia/drug therapy/*genetics/pathology MH - Male MH - Phenotype MH - Proto-Oncogene Proteins c-abl/*genetics MH - Sensitivity and Specificity MH - *Translocation, Genetic EDAT- 2004/06/15 05:00 MHDA- 2004/07/28 05:00 CRDT- 2004/06/15 05:00 PHST- 2003/07/31 00:00 [received] PHST- 2003/10/17 00:00 [revised] PHST- 2003/10/20 00:00 [accepted] PHST- 2004/06/15 05:00 [pubmed] PHST- 2004/07/28 05:00 [medline] PHST- 2004/06/15 05:00 [entrez] AID - S0165460803004679 [pii] AID - 10.1016/j.cancergencyto.2003.10.014 [doi] PST - ppublish SO - Cancer Genet Cytogenet. 2004 Jul 1;152(1):81-3. doi: 10.1016/j.cancergencyto.2003.10.014.